VERTEX PHARMACEUTICALS INC

Ticker: VRTX CUSIP: 92532F100 Class: EQTY

Nilsine Partners, LLC's Holding History (CIK: 0001913043)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,781 Value ($000) $1,714 Avg Close $431.03 Range $392.50 - $464.44
Q3 2025
Shares 3,552 Value ($000) $1,391 Avg Close $417.92 Range $362.50 - $484.56
Q2 2025
Shares 3,725 Value ($000) $1,658 Avg Close $460.83 Range $416.60 - $510.77
Q1 2025
Shares 3,720 Value ($000) $1,804 Avg Close $466.00 Range $397.25 - $519.68
Q4 2024
Shares 3,204 Value ($000) $1,290 Avg Close $463.53 Range $377.85 - $519.88
Q3 2024
Shares 3,202 Value ($000) $1,489 Avg Close $480.37 Range $456.07 - $510.64
Q2 2024
Shares 3,450 Value ($000) $1,617 Avg Close $434.05 Range $391.01 - $486.43
Q1 2024
Shares 3,481 Value ($000) $1,455 Avg Close $422.74 Range $403.43 - $448.40
Q4 2023
Shares 3,552 Value ($000) $1,445 Avg Close $369.42 Range $341.85 - $413.00
Q3 2023
Shares 5,312 Value ($000) $1,847 Avg Close $349.73 Range $335.82 - $367.00
Q2 2023
Shares 4,219 Value ($000) $1,485 Avg Close $336.94 Range $313.47 - $354.94
Q1 2023
Shares 4,180 Value ($000) $1,317 Avg Close $299.93 Range $282.21 - $325.19